HYVALTUS Trademark

Trademark Overview


On Friday, February 2, 2018, a trademark application was filed for HYVALTUS with the United States Patent and Trademark Office. The USPTO has given the HYVALTUS trademark a serial number of 87781750. The federal status of this trademark filing is REGISTERED as of Tuesday, October 29, 2019. This trademark is owned by Celltrion, Inc.. The HYVALTUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurogenic detrusor overactivity; drugs being pharmaceutical preparations for the treatment of iron overload, migraine and diabetes; medicines for the treatment of cardiac, neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders; ethical medicinal preparations for prevention and treatment of low blood pressure; biological preparations for medical purposes for the treatment of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical products for the treatment of viral diseases; vaccines; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune diseases; anti-infectives; antivirals; antibiotics; antiepileptic drugs, namely, anti-epileptic pharmaceutical preparations; dietary supplements; vitamin and mineral preparation...
hyvaltus

General Information


Serial Number87781750
Word MarkHYVALTUS
Filing DateFriday, February 2, 2018
Status700 - REGISTERED
Status DateTuesday, October 29, 2019
Registration Number5894131
Registration DateTuesday, October 29, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 13, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of neurogenic detrusor overactivity; drugs being pharmaceutical preparations for the treatment of iron overload, migraine and diabetes; medicines for the treatment of cardiac, neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders; ethical medicinal preparations for prevention and treatment of low blood pressure; biological preparations for medical purposes for the treatment of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical products for the treatment of viral diseases; vaccines; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune diseases; anti-infectives; antivirals; antibiotics; antiepileptic drugs, namely, anti-epileptic pharmaceutical preparations; dietary supplements; vitamin and mineral preparations for medical use; pharmaceuticals, namely, pharmaceutical preparations for the prevention of HIV/AIDS infection; pharmaceuticals, namely, pharmaceutical preparations for the treatment of HIV/AIDS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 12, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelltrion, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressINCHEON
KR

Party NameCelltrion, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressINCHEON
KR

Party NameCelltrion, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressINCHEON
KR

Trademark Events


Event DateEvent Description
Tuesday, February 6, 2018NEW APPLICATION ENTERED
Monday, February 12, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 15, 2018ASSIGNED TO EXAMINER
Wednesday, May 16, 2018NON-FINAL ACTION WRITTEN
Wednesday, May 16, 2018NON-FINAL ACTION E-MAILED
Wednesday, May 16, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 6, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 23, 2018ASSIGNED TO LIE
Monday, August 27, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 27, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 27, 2018SUSPENSION LETTER WRITTEN
Monday, August 27, 2018LETTER OF SUSPENSION E-MAILED
Monday, August 27, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, January 2, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, January 3, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 3, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 24, 2019NON-FINAL ACTION WRITTEN
Thursday, January 24, 2019NON-FINAL ACTION E-MAILED
Thursday, January 24, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 2, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 2, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 2, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 17, 2019ASSIGNED TO EXAMINER
Saturday, July 6, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 24, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 13, 2019PUBLISHED FOR OPPOSITION
Tuesday, August 13, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 29, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, October 29, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED